Dept. of Gastroenterology,
Infectiology and Rheumatology

> FU Berlin / HU Berlin
 
> Charité     CBF
  > Departments    CC13
   > Inst. Clin. Physiology
    > Research associates
     > Hans-Jörg Epple

  

Cooperation partner of the Inst. of Clinical Physiology

Priv.-Doz.* Dr. med.
Hans-Jörg Epple
e-mail  hans-joerg.epple@charite.de


*Priv.-Doz. = Assistant professor (US), Lecturer (UK)
 

Research topics

Publications

 

Grants German Research Foundation (DFG)

2017 - 2022

Epple,
Schneider

Project C4 "Macromolecule uptake across the mucosa in HIV infection", in:
DFG Research Training Group (GRK 2318) "Tight junctions and their proteins: molecular features and actions in health and disease (TJ-Train)"

CV

1985 – 1992

Study of Medicine Karl-Rupprechts-Universität Heidelberg and Freie Universität Berlin
1992 – 1993 Doctoral thesis "Experimentelle Untersuchungen zum Mechanismus der mineralocorticoiden Wirkung von Carbenoxolon am menschlichen Dickdarm in vitro", Dept. of Clinical Physiology, Freie Universität Berlin (supervision: Prof. M. Fromm)
1993 – 1995 Internship, Medical Clinic, Department for Internal Medicine / Gastroenterology, Klinikum Steglitz, Freie Universität Berlin (Director: Prof. E. O. Riecken)
06/1995 Approbation
1995 – 2007 Residency, Department for Internal Medicine / Gastroenterology, Klinikum Steglitz, Freie Universität Berlin (Director: Prof. Dr. E. O. Riecken) and Medical Clinic Gastroenterology, Infectious Diseases, Rheumatology, Charité – Universitätsmedizin Berlin, Campus Benjamin Franklin (Director: Prof. M. Zeitz)
2006 Specialist in Internal Medicine (Facharztanerkennung)
2007 Specialist for Infectious Diseases (Deutsche Gesellschaft für Infektiologie, Zusatz­weiter­bildung Ärztekammer Berlin)
since 2007 Consultant (Oberarzt) Medical Clinic Gastroenterology, Infectious Diseases, Rheumatology, Charité – Universitätsmedizin Berlin, Campus Benjamin Franklin (Director: Prof. M. Zeitz
2011 Habilitation in Internal Medicine. Habilitation thesis on barrier function in infections of the intestinal mucosa (“Einfluss lokaler und systemischer mukosaler Infektionen auf Barriere­funktion und Immunsystem der Darmschleimhaut“)